慢性炎症性脱髓鞘性多发性神经病（CIDP）中从静脉注射免疫球蛋白（IVIG）转换为FcRn抑制的应对策略：临床见解 - Suppr | 超能文献

Navigating the switch from IVIG to FcRn inhibition in CIDP: Clinical insights.

作者信息

Karam Chafic

机构信息

University of Pennsylvania, Philadelphia, PA, United States.

出版信息

J Neurol Sci. 2025 Jan 15;468:123354. doi: 10.1016/j.jns.2024.123354. Epub 2024 Dec 16.

DOI:10.1016/j.jns.2024.123354

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Navigating the switch from IVIG to FcRn inhibition in CIDP: Clinical insights.慢性炎症性脱髓鞘性多发性神经病（CIDP）中从静脉注射免疫球蛋白（IVIG）转换为FcRn抑制的应对策略：临床见解

J Neurol Sci. 2025 Jan 15;468:123354. doi: 10.1016/j.jns.2024.123354. Epub 2024 Dec 16.

2

Early deterioration of CIDP following transition from IVIG to FcRn inhibitor treatment.从静脉注射免疫球蛋白（IVIG）过渡到FcRn抑制剂治疗后慢性炎性脱髓鞘性多发性神经病（CIDP）的早期恶化。

J Neurol Sci. 2025 Jan 15;468:123313. doi: 10.1016/j.jns.2024.123313. Epub 2024 Nov 17.

3

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors.新生儿Fc受体（FcRn）在神经免疫疗法中的重要性：从IgG分解代谢、基因多态性、静脉注射免疫球蛋白剂量和疗效到特定的FcRn抑制剂

Ther Adv Neurol Disord. 2021 Feb 26;14:1756286421997381. doi: 10.1177/1756286421997381. eCollection 2021.

4

Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis.在慢性神经炎动物模型中，靶向新生儿Fc受体（FcRn）并无益处。

Immunol Res. 2024 Dec 15;73(1):12. doi: 10.1007/s12026-024-09565-7.

5

[Pathomechanism Underlying Intravenous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy].[静脉注射免疫球蛋白治疗慢性炎性脱髓鞘性多发性神经病的发病机制]

Brain Nerve. 2024 Oct;76(10):1109-1118. doi: 10.11477/mf.1416202746.

6

Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions.慢性炎性脱髓鞘性多发性神经病（CIDP）患者从静脉注射免疫球蛋白转换为皮下注射IgPro20：一项真实世界条件下的前瞻性观察研究

Ther Adv Neurol Disord. 2021 Apr 16;14:17562864211009100. doi: 10.1177/17562864211009100. eCollection 2021.

7

Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经根神经病（CIDP）：作用机制及临床和遗传学考量

Expert Rev Neurother. 2022 Nov-Dec;22(11-12):953-962. doi: 10.1080/14737175.2022.2169134. Epub 2023 Jan 23.

8

Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study.慢性炎性脱髓鞘性多发性神经根神经病患者静脉注射免疫球蛋白起始治疗：一项基于美国索赔数据的队列研究

Neurol Ther. 2023 Aug;12(4):1171-1186. doi: 10.1007/s40120-023-00479-4. Epub 2023 May 17.

9

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study.CIDP：COVID-19 mRNA 疫苗接种和 IVIg 免疫调节期间免疫标志物的分析：一项探索性研究。

J Neuroimmune Pharmacol. 2023 Jun;18(1-2):208-214. doi: 10.1007/s11481-023-10058-x. Epub 2023 Mar 16.

10

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.慢性炎症性脱髓鞘性多发性神经病（CIDP）：静脉注射免疫球蛋白治疗期间血清IgG二聚体水平的变化

J Neuroinflammation. 2015 Aug 14;12:148. doi: 10.1186/s12974-015-0361-1.

引用本文的文献

1

Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.自身免疫性疾病中靶向新生儿Fc受体：研发进程与进展

BioDrugs. 2025 May;39(3):373-409. doi: 10.1007/s40259-025-00708-2. Epub 2025 Mar 29.